APA (7th ed.) Citation

Singhal, M., Tan, H., Coleman, C. I., Han, M., Nguyen, C., & Ingham, M. Effectiveness, treatment durability, and treatment costs of canagliflozin and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes in the USA. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Singhal, Mukul, Hiangkiat Tan, Craig I. Coleman, Michelle Han, Chi Nguyen, and Michael Ingham. Effectiveness, Treatment Durability, and Treatment Costs of Canagliflozin and Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes in the USA. BMJ Publishing Group.

MLA (9th ed.) Citation

Singhal, Mukul, et al. Effectiveness, Treatment Durability, and Treatment Costs of Canagliflozin and Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes in the USA. BMJ Publishing Group.